Identifying Markers of Disease Subtypes and Disease Progression in the Syndrome of Essential Tremor
- Conditions
- Essential Tremor
- Interventions
- Diagnostic Test: Clinical examination, blood draw, cerebral MRI, sonography, tremor analysis, OCT, olfactory mucosa swab.
- Registration Number
- NCT06349538
- Lead Sponsor
- Medical University of Graz
- Brief Summary
The goal of this observational study is to learn about epidemiology, biologic markers, disease subtypes and possible prognostic factors in essential tremor (ET) patients. The main question\[s\] it aims to answer are:
* The prevalence of ET-plus compared to ET in a prospectively collected ET population.
* To assess in detail the heterogenous group of ET patients using comprehensive clinical (motor and non-motor scales, questionnaires), imaging \[magnetic resonance imaging (MRI), sonography of substantia nigra and cerebral vessels\], neurophysiological (tremor analysis, digital spiral drawing) and laboratory markers (sGFAP, sNfL, routine laboratory parameters).
* To assess possible non-invasive markers of neurodegeneration in ET patients (optic coherence tomography, alpha-synuclein in olfactory mucosa)
Participants will be asked to undergo the above mention evaluation at baseline and at follow-up approx. 5 years later.
Researchers will compare the findings within the ET group to independently existing cohorts of healthy controls and/or patients with other movement disorders like Parkinson's disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 100
- Presence of an essential tremor syndrome according to MDS consensus criteria or suspected incipient essential tremor (differential diagnosis vs. enhanced physiological tremor)
- Patient is able and willing to give informed consent.
- age above 18 years.
- Patient is not able or not willing to give informed consent.
- Existence of a legal representative.
- age below 18 years
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Essential tremor patients Clinical examination, blood draw, cerebral MRI, sonography, tremor analysis, OCT, olfactory mucosa swab. Essential tremor patients will undergo a detailed clinical examination incl. motor/non motor scoring systems and questionnaires, blood draw, sonography, tremor analysis and cerebral MRI. Additionally, essential tremor patients will undergo optic coherence tomography and olfcatory mucosa swab for alpha-synuclein. All tests are conducted at baseline as well as at a follow-up examination 5 years later. No drugs or other interventions are to be administered
- Primary Outcome Measures
Name Time Method Prevalence of ET-plus approx. 2 years Determine the prevalence of ET-plus within a prospectively collected ET population
- Secondary Outcome Measures
Name Time Method Symptom leading to ET-plus classification 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) e.g. rest tremor, impaired tandem gait, mild parkinsonian signs, questionable dystonia, mild cognitive impairment
presence of cardiovascular risk factors 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) arterial hypertension yes vs. no, hyperlipidemia yes vs. no, smoking yes vs. no vs. former, diabetes mellitus yes vs. no, coronary artery disease yes vs. no
Boston Naming Test (part of the CERAD-plus test battery) 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patient needs to name 15 items (shown as pictures) correctly, the more, the better
word list learning (part of the CERAD-plus test battery) 10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patient is shown 10 words which he needs to remember and repeat immediately after reading them (within 90 seconds); there a three tries; the more he remembers, the better
Age of ET patients 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) age at disease onset and age at baseline
MDS-UPDRS (Movement Disorder Society Unified Parkinson's Disease Rating Scale) parts I-IV 20-30 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) rates clinical severity of parkinsonian symptoms, range 0-260 points with higher points meaning more severe symptoms
responsivity to alcohol 1 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) amelioration of tremor severity after consumption of alcohol (yes vs. no vs. unknown)
Scale for the assessment and rating of ataxia (SARA) 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) assesses symptoms of ataxia, ranging from 0 (no ataxia) to 40 (most severe ataxia)
constructive praxis (part of the CERAD-plus test battery) 20-30 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patient needs to draw 4 figures from a model which are then rated according to prespecified criteria (maximum of 11 points, the more the better)
Trail Making Test B (part of the CERAD-plus test battery) 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patient needs to connect numbers and letters in ascending and alternating order from 1 to 13 and A to L, respectively, time is measured in seconds (the faster, the better)
Non-Motor Symptoms Scale for Parkinson's Disease (NMSS) 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a questionnaire rating non motor symptoms, ranging from 0 (no symptoms) to 128 (most severe non motor symptoms)
Sex of ET patients 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) male, female, other
Family history 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) positive or negative for essential tremor or Parkinson's disease
current and former medication for essential tremor 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) e.g. propranolol yes vs no, topiramate yes vs no, primidone yes vs no
subjective disease course of ET 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) no progression, slowly and continuously, relapsing, plateau-like after initial progression, rapidly progressive
modified Essential Tremor Rating Assessment Scale (mTETRAS) 10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) rates clinical severity of ET symptoms, ranging from 0-80 (the "modified" means the inclusion of 2 additional items rating rest tremor) with higher points meaning more severe motor symptoms; also includes a subscale rating activities of daily living ranging from 0-48 points with more points meaning more severe disability due to ET
resilience scale (RS-13) 1-2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a quick questionnaire rating resilience, ranging from 13 (least resilience) to 91 points (highest resilience)
Pittsburgh Sleep Quality Index (PSQI) 3-4 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a quick questionnaire rating sleep quality, ranging from 0 (best sleep) to 21 points (worst sleep quality)
Verbal fluency animals (part of the CERAD-plus test battery) 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) patients needs to say as many animals as possible within 1 minute, the more, the better
word list recall (part of the CERAD-plus test battery) 90 seconds; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patient needs to remember as many of the 10 words learned in "word list learning"; time limit 90 seconds
Global Physical Activity Questionnaire (GPAQ) 5-7 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the GPAQ is a questionnaire provided by the WHO and rates the extent of physical (-in-) activity; rating is done according to the WHO manual available from the WHO website
Montreal Cognitive Assessment (MOCA) 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a screening cognitive test rating cognitive dysfunction from 0 (worst) to 30 (best)
serum glial fibrillary acidic protein (sGFAP) 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) sGFAP-level is measured from serum using SIMOA-technology
optic coherence tomography (OCT) 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) thickness of choroidea in both eyes and each quadrant and in vicinity of the macula and papilla
Mini Mental State Examination Test (MMSE; part of the CERAD-plus test battery) 3-5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a cognitive screening test with a minimum of 0 and a maximum of 30 points
word list recognition (part of the CERAD-plus test battery) 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patient needs decide whether a word shown to him was part of the 10 words learned before; there a 20 words in total, and 10 each were part of the learned words while 10 where not; the more he/she remembers correctly, the better (1 point for each correctly identified word)
Frontal Assessment Battery (FAB) 5 - 10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a neuropsychological test focusing on executive function, ranging from 0 (most impaired) to 18 (normal)
Geriatric Depression Scale (GDS) 3-5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a short questionnaire rating depressive symptoms, ranging from 0 (no depressive symptoms) to 15 (most severe depressive symptoms)
Auditory verbal learning test 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) assesses how well patients can remember 15 words after hearing them; the more they can remember, the better
Brief Visuospatial Memory Test 2-3 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) patients can look at 6 figures for 10 seconds each, then they have to reproduce them; 3 trials; the more they remember, the better
Comprehensive trail making test 5 1-2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) patients have to connect numbers (1 to 13) and letters (A to L) in ascending order and alternatingly with lines; time is measured in seconds; the faster, the better
Regensburg word fluency test 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) patients have to list words starting with "g" or "r" alternatingly or things within the categories of "clothes" or "flowers" alternatingly; they have 1 minute for each of the two tasks, the more they can list, the better
EQ-5D 1-2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a quick questionnaire (5 questions) rating quality of life, ranging from 0 (very bad) to 1 (best)
RBD Screening Questionnaire 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) rates probability for the presence of RBD (REM sleep behavior disorder) using 13 questions; points are given from 0 to 13 with higher points indicating a higher probability for RBD
Quality of Life in Essential Tremor Questionnaire (QUEST) 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a questionnaire rating quality of life specifically in ET patients; ranging from 0 (best quality of life) to 120 points (worst quality of life)
Comprehensive trail making test 4 1-2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) patients have to connect numbers (1 to 21) in ascending order with lines; time is measured in seconds; the faster, the better
Schellong Test 3.5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) blood pressure test for orthostatic hypotension; blood pressure is measured non-invasively using a automatic device at the left arm in seating position and after 1 and 3 minutes of standing; orthostatic hypotension is defined as a drop in systolic blood pressure of 20mmHg or more and/or of diastolic blood pressure of 10mmHg or more
constructive praxis recall (part of the CERAD-plus test battery) 3-4 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patients needs to draw the 4 figures from "constructive praxis" from memory; they are then rated according to the same criteria with a maximum of 11 points
Trail Making Test A (part of the CERAD-plus test battery) 2 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patient needs to connect numbers in ascending order from 1 to 25, time is measured in seconds (the faster, the better)
s-words (part of the CERAD-plus test battery) 1 minute; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the patient needs to list as many words starting with the letter "s" within 60 seconds as possible; the more the better
Hospital Anxiety and Depression Scale (HADS) 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a questionnaire rating anxiety and depressive symptoms, ranging from 0 (no depressive/anxious symptoms) to 42 (most severe symptoms)
University of Pennsylvania Smell Identification Test (UPSIT) 10-15 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) a smell test ranging from 0 (worst olfactory function) to 40 points (best olfactory function)
Symbol Digit Modalities Test (SDMT) 90 seconds; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) patients need to translate specific symbols into numbers (1-9) using a key; they more the can translate in 90 seconds, the better
Digital Spiral Drawing 2-3 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) patients are asked to draw Archimedes spirals (a total of 4, 2 with each hand) on a standard tablet PC using a touchpen; the process is done using a free available website-based application (http://www.trsper.com/); the main outcome is visual rating of the spirals ranging from 0 (perfectly normal) to 9 (worst spiral)
Transcranial sonography 10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) the presence of hyperechogenicity (yes/no and area in cm2) of the substantia nigra is measured using transcranial sonography
cerebral MRI 45 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) nigrosome-1-imaging (presence of swallow tail sign yes vs. no)
Olfactory mucosa swab 5-10 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) swab of the olfactory mucosa testing for alpha-synuclein using a seeding assay (outcome: presence of misfolded alpha-synuclein yes vs. no)
serum neurofilament light (sNfL) 5 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) sNfL-level is measured from serum using SIMOA-technology
tremor analysis 20 minutes; Baseline (recruiting time approx. 2 years) and follow-up (5 years after individual baseline) tremor frequency and total tremor power are measured
Trial Locations
- Locations (1)
Medical University of Graz
🇦🇹Graz, Austria